Oct 14, 2026 06:30AM
Oct 14, 2026 06:30AM
Oct 12, 2026 06:05AM
Oct 6, 2026 06:32AM
Oct 6, 2026 06:30AM
Sep 22, 2026 08:30AM
Sep 22, 2026 08:30AM Quoin Pharmaceuticals Announces FDA Fast Track Designation for QRX003 for the Treatment of Peeling Skin Syndrome
Sep 10, 2026 08:30AM
Aug 28, 2026 06:00AM
Aug 28, 2026 06:00AM
Aug 14, 2026 08:30AM
Jul 9, 2026 08:30AM
Jul 9, 2026 08:30AM
Jun 30, 2026 08:31AM Quoin Pharmaceuticals receives U.S. patent allowance for Netherton drug
Jun 30, 2026 08:30AM
Jun 23, 2026 08:31AM
Jun 23, 2026 08:30AM
Jun 18, 2026 08:31AM
Jun 18, 2026 08:30AM
Jun 4, 2026 08:31AM
Jun 4, 2026 08:30AM Quoin Pharmaceuticals Announces Japan's MHLW Grants Orphan Drug Designation for QRX003 in Netherton Syndrome
Jun 2, 2026 08:31AM
Jun 2, 2026 08:30AM
May 7, 2026 08:30AM
Apr 28, 2026 12:02PM
Apr 28, 2026 08:32AM
Apr 28, 2026 08:30AM
Mar 26, 2026 08:30AM Quoin Pharmaceuticals Provides Corporate Update and Reports Fourth Quarter and Full-Year 2025 Financial Results
Mar 25, 2026 08:31AM
Mar 25, 2026 08:30AM
Mar 11, 2026 08:30AM
Mar 11, 2026 08:30AM
Jan 27, 2026 08:31AM
Jan 27, 2026 08:30AM
Jan 20, 2026 08:30AM Quoin Pharmaceuticals Files Breakthrough Medicine Designation Application in Saudi Arabia for QRX003 in Netherton Syndrome
Nov 11, 2025 08:31AM
Nov 11, 2025 08:30AM
Nov 6, 2025 08:30AM
Oct 21, 2025 08:30AM
Oct 21, 2025 08:30AM
Oct 10, 2025 09:25AM
Oct 10, 2025 09:24AM Quoin Pharmaceuticals Announces Private Placement Financing of Up to $104.5 Million
Aug 7, 2025 08:30AM
Jun 26, 2025 08:30AM
Jun 24, 2025 08:34AM
Jun 24, 2025 08:30AM
May 22, 2025 07:31AM
May 22, 2025 07:30AM
May 13, 2025 08:00AM Quoin Pharmaceuticals Provides Corporate Update and Announces First Quarter 2025 Financial Results
Apr 10, 2025 07:30AM

334,273 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All